Effect of reducing LH level on ovulation induction and pregnancy outcome in patients with polycystic ovary syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035600

Enrollment

Unknown

Registered

2020-08-14

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

group A:Dydrogesterone and Antagonists (GnRHA)

group B:Dydrogesterone

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Compliance with Rotterdam PCOS diagnostic criteria and basal LH > FSH; 2. Compliance with the diagnostic criteria of infertility; 3. Mild oligofragile teratozoa in male semen can be assessed by a male physician for IUI; 4. Female salpingography suggests bilateral tubal patency (contrast-enhanced ultrasound or lipiodol contrast).

Exclusion criteria

Exclusion criteria: Combined with other systemic diseases, not suitable for pregnancy.

Design outcomes

Primary

Measure	Time frame
pregnancy rate;	—

Secondary

Measure	Time frame
clinical pregnancy rate;early pregnancy rate;ongoing pregnancy rate;live birth rate;Preterm birth rate;Changes of LH level before and during the ovulation induction;days of ovulation induction;Doses of Gn during the ovulation induction;	—

Countries

China

Contacts

Public ContactQiong Wang

Reproductive Center of the First Affiliated Hospital of Sun Yat-Sen University

wangqionggz@hotmail.com+86 13609023332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026